Randomized Controlled Trial
Copyright ©The Author(s) 2025.
World J Gastroenterol. Apr 7, 2025; 31(13): 100863
Published online Apr 7, 2025. doi: 10.3748/wjg.v31.i13.100863
Figure 1
Figure 1 Flow chart of patient recruitment. A: The study of 14-day esomeprazole and amoxicillin high-dose dual therapy and 14-day bismuth-containing quadruple therapy (14-day esomeprazole, amoxicillin, clarithromycin, and bismuth therapy); B: The study of 14-day vonoprazan and amoxicillin high-dose dual therapy and 14-day vonoprazan, amoxicillin, and clarithromycin therapy. ITT: Intention-to-treat; mITT: Modified intention-to-treat; PP: Per-protocol; UBT: Urea breath test; EA: Esomeprazole-amoxicillin; B-quadruple: Esomeprazole-amoxicillin-clarithromycin-bismuth; VA: Vonoprazan-amoxicillin; VAC: Vonoprazan-amoxicillin-clarithromycin.